Mounjaro vs Wegovy: Complete Comparison Guide
Understanding What Makes Mounjaro And Wegovy Different
When exploring what is the difference between Mounjaro and Wegovy, the primary distinction lies in their molecular mechanisms of action. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro, conversely, contains tirzepatide—a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that targets two distinct pathways simultaneously. This dual-action approach may influence how each medication affects appetite regulation, though both are prescription-only medicines requiring clinical assessment.
The practical implications of understanding what is the difference between Mounjaro and Wegovy extend beyond mechanism to real-world usage patterns. Wegovy follows a five-dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) over 16 weeks to maintenance, whilst Mounjaro uses six doses (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg) with different titration timing. Both medications require weekly injections using pre-filled pens, but the dosing progression differs significantly. EverydayMeds stocks both options, allowing your prescriber to recommend the most suitable choice based on your individual clinical profile and tolerance patterns.
Wegovy vs Mounjaro Pricing And Value Comparison
The cost difference between Mounjaro and Wegovy varies significantly across dose levels at EverydayMeds. Wegovy starter doses begin at £79.99 for 0.25mg (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning patients use DOSE25 to reach these final prices. Our Getting Started bundles provide convenient dose progression packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99.
Mounjaro pricing follows a different structure reflecting its unique dosing schedule, with costs varying by strength and supply duration. When comparing what is the difference between Mounjaro and Wegovy from a financial perspective, consider the total monthly cost at maintenance doses rather than just starter pricing. EverydayMeds offers both 2-pen and 3-pen bundle options for extended supply security, with our Take-It-Slow bundles accommodating patients requiring gentler dose escalation. The Ultimate Stability Trio provides three months of maintenance supply for consistent dosing without monthly reordering.
Clinical Evidence For Mounjaro Versus Wegovy Effectiveness
Clinical trial data helps illustrate what is the difference between Mounjaro and Wegovy regarding potential outcomes. In the STEP programme trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's SURMOUNT trial programme evaluated tirzepatide's dual-action mechanism in weight management contexts. However, directly comparing trial percentages between medications isn't appropriate due to different study designs, patient populations, and primary endpoints. Both medications work alongside a reduced-calorie diet and increased physical activity, with individual responses varying considerably based on adherence, lifestyle factors, and metabolic characteristics.
How Wegovy's GLP-1 Mechanism Works
Wegovy's semaglutide acts specifically on GLP-1 receptors throughout your body, particularly in brain regions controlling appetite and food intake. This targeted action mimics naturally occurring GLP-1 hormone that's released after eating to signal fullness and satisfaction. By enhancing this natural pathway, Wegovy may help reduce food cravings and promote feeling satisfied with smaller portion sizes. The medication also slows gastric emptying, meaning food stays in your stomach longer to extend feelings of fullness. Clinical assessment determines whether this mechanism suits your individual weight management needs and medical history.
EverydayMeds Ordering Process For Both Medications
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (or 24 hours with express service) to determine suitability for either treatment option. Once approved, medications are dispatched via next-day delivery using temperature-controlled cold-chain packaging to maintain efficacy. Our GPhC-registered pharmacy (#9012878) ensures all medications are genuine and stored according to manufacturer specifications. Patient support continues throughout treatment with accessible clinical guidance for dose adjustments or side effect management.
Storage Requirements And Practical Considerations
Understanding what is the difference between Mounjaro and Wegovy includes crucial storage distinctions affecting travel and daily use. Wegovy pens must be stored in the fridge at 2-8°C before first use, but can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. Mounjaro has a shorter room temperature tolerance of just 21 days, making Wegovy more convenient for extended travel or variable storage situations. Both medications use different pen devices—Wegovy employs Novo Nordisk's FlexTouch system whilst Mounjaro uses Eli Lilly's proprietary injector design. Dose escalation timing also differs, with some patients finding one schedule more tolerable than the other.
Choosing Between Dual-Action And Single-Receptor Approaches
The fundamental question of what is the difference between Mounjaro and Wegovy often centres on whether dual-receptor activation offers advantages over single-pathway targeting. Mounjaro's simultaneous GIP and GLP-1 receptor stimulation theoretically provides broader metabolic effects, whilst Wegovy's focused GLP-1 action offers well-established clinical experience. Neither approach is inherently superior—the choice depends on individual response patterns, tolerability profiles, and clinical circumstances.
EverydayMeds' unique advantage lies in offering both treatment options through the same clinical pathway, allowing prescribers to recommend switches if initial treatment doesn't provide optimal results. This flexibility means you're not locked into a single medication approach, with expert guidance available for transitioning between treatments if clinically appropriate. Both remain prescription-only medicines requiring ongoing clinical oversight and lifestyle modification support.
Complete Treatment Access With Expert Support
EverydayMeds eliminates the complexity of choosing between these treatments by providing access to both Wegovy and Mounjaro through our streamlined clinical service. Our prescribers can recommend the most appropriate option based on your complete medical picture, previous treatment responses, and practical considerations like storage requirements or injection preferences. New customers benefit from FIRST40 discount code application, whilst returning patients use DOSE25 for continued savings. Clinical support continues throughout your treatment journey with accessible advice for optimising results alongside dietary and exercise modifications. Choose EverydayMeds for expert guidance in navigating what is the difference between Mounjaro and Wegovy with confidence in your treatment decision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
